de Boer PT - Search Results

1

A systematic review of the health economic consequences of quadrivalent influenza vaccination.

de Boer PT, van Maanen BM, Damm O, Ultsch B, Dolk FCK, Crépey P, Pitman R, Wilschut JC, Postma MJ. de Boer PT, et al. Expert Rev Pharmacoecon Outcomes Res. 2017 Jun;17(3):249-265. doi: 10.1080/14737167.2017.1343145. Epub 2017 Jun 28. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28613092 Free article. Review.

2

Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control.

Van Maanen BM, de Boer PT, Dolk FC, Friedrich AW, Wilschut JC, Pitman R, Postma MJ. Van Maanen BM, et al. Among authors: de boer pt. Expert Rev Vaccines. 2017 Jan;16(1):1-4. doi: 10.1080/14760584.2016.1221347. Epub 2016 Aug 19. Expert Rev Vaccines. 2017. PMID: 27539516 Free article. No abstract available.

3

Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014.

Crépey P, de Boer P, Postma MJ, Pitman RJ. Crépey P, et al. Value Health. 2014 Nov;17(7):A664-5. doi: 10.1016/j.jval.2014.08.2446. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202425 Free article. No abstract available.

4

Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.

de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ. de Boer PT, et al. Vaccine. 2013 Feb 18;31(9):1276-83. doi: 10.1016/j.vaccine.2012.12.067. Epub 2013 Jan 8. Vaccine. 2013. PMID: 23306360

5

Cost-effectiveness of vaccination against herpes zoster.

de Boer PT, Wilschut JC, Postma MJ. de Boer PT, et al. Hum Vaccin Immunother. 2014;10(7):2048-61. doi: 10.4161/hv.28670. Hum Vaccin Immunother. 2014. PMID: 25424815 Free PMC article. Review.

6

Retrospective public health impact of a quadrivalent influenza vaccine in the United States.

Crépey P, de Boer PT, Postma MJ, Pitman R. Crépey P, et al. Among authors: de boer pt. Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1(Suppl 1):39-46. doi: 10.1111/irv.12318. Influenza Other Respir Viruses. 2015. PMID: 26256294 Free PMC article.

7

Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.

de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ. de Boer PT, et al. Value Health. 2016 Dec;19(8):964-975. doi: 10.1016/j.jval.2016.05.012. Epub 2016 Jul 15. Value Health. 2016. PMID: 27987647 Free article.

8

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.

de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ. de Boer PT, et al. Vaccine. 2018 Feb 8;36(7):997-1007. doi: 10.1016/j.vaccine.2017.12.073. Epub 2018 Jan 17. Vaccine. 2018. PMID: 29373192 Free PMC article.

9

Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach.

Dolk FCK, de Boer PT, Nagy L, Donker GA, Meijer A, Postma MJ, Pitman R. Dolk FCK, et al. Among authors: de boer pt. Value Health. 2021 Jan;24(1):11-18. doi: 10.1016/j.jval.2020.10.013. Epub 2020 Dec 9. Value Health. 2021. PMID: 33431142 Free article.

10

Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.

de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ. de Boer PT, et al. Value Health. 2021 Jan;24(1):19-31. doi: 10.1016/j.jval.2020.10.011. Epub 2020 Dec 11. Value Health. 2021. PMID: 33431149 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters